NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
03 2023
Historique:
entrez: 10 3 2023
pubmed: 11 3 2023
medline: 15 3 2023
Statut: ppublish

Résumé

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for individuals with a prostate who opt to participate in an early detection program after receiving the appropriate counseling on the pros and cons. These NCCN Guidelines Insights provide a summary of recent updates to the NCCN Guidelines with regard to the testing protocol, use of multiparametric MRI, and management of negative biopsy results to optimize the detection of clinically significant prostate cancer and minimize the detection of indolent disease.

Identifiants

pubmed: 36898362
doi: 10.6004/jnccn.2023.0014
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

236-246

Auteurs

Kelvin A Moses (KA)

Vanderbilt-Ingram Cancer Center.

Preston C Sprenkle (PC)

Yale Cancer Center/Smilow Cancer Hospital.

Clinton Bahler (C)

Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Geoffrey Box (G)

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Sigrid V Carlsson (SV)

Memorial Sloan Kettering Cancer Center.

William J Catalona (WJ)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Douglas M Dahl (DM)

Massachusetts General Hospital Cancer Center.

Marc Dall'Era (M)

UC Davis Comprehensive Cancer Center.

John W Davis (JW)

The University of Texas MD Anderson Cancer Center.

Bettina F Drake (BF)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Jonathan I Epstein (JI)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Ruth B Etzioni (RB)

Fred Hutchinson Cancer Center.

Thomas A Farrington (TA)

Prostate Health Education Network.

Isla P Garraway (IP)

UCLA Jonsson Comprehensive Cancer Center.

David Jarrard (D)

University of Wisconsin Carbone Cancer Center.

Eric Kauffman (E)

Roswell Park Comprehensive Cancer Center.

Deborah Kaye (D)

Duke Cancer Institute.

Adam S Kibel (AS)

Dana-Farber/Brigham and Women's Cancer Center.

Chad A LaGrange (CA)

Fred & Pamela Buffett Cancer Center.

Paul Maroni (P)

University of Colorado Cancer Center.

Lee Ponsky (L)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Brian Reys (B)

UT Southwestern Simmons Comprehensive Cancer Center.

Simpa S Salami (SS)

University of Michigan Rogel Cancer Center.

Alejandro Sanchez (A)

Huntsman Cancer Institute at the University of Utah.

Tyler M Seibert (TM)

UC San Diego Moores Cancer Center.

Terrence M Shaneyfelt (TM)

O'Neal Comprehensive Cancer Center at UAB.

Marc C Smaldone (MC)

Fox Chase Cancer Center.

Geoffrey Sonn (G)

Stanford Cancer Institute.

Mark D Tyson (MD)

Mayo Clinic Cancer Center.

Neha Vapiwala (N)

Abramson Cancer Center at the University of Pennsylvania.

Robert Wake (R)

St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

Samuel Washington (S)

UCSF Helen Diller Family Comprehensive Cancer Center.

Alice Yu (A)

Moffitt Cancer Center.

Bertram Yuh (B)

City of Hope National Medical Center.

Ryan A Berardi (RA)

National Comprehensive Cancer Network.

Deborah A Freedman-Cass (DA)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH